Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.206% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a COCCNC(=O)c1nc2c(nnn2Cc2cc(C)ccc2C)c(=O)[nH]1
b O=C1CCCN1C(=O)CSc1nnnn1-c1ccccc1
Answer: a. COCCNC(=O)c1nc2c(nnn2Cc2cc(C)ccc2C)c(=O)[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCNC(=O)c1nc2c(nnn2Cc2cc(C)ccc2C)c(=O)[nH]1
COCCNC(=O)c1nc2c(nnn2Cc2cc(C)ccc2C)c(=O)[nH]1
3-[(2,5-dimethylphenyl)methyl]-N-(2-methoxyethyl)-7-oxo-6H-triazolo[4,5-d]pyrimidine-5-carboxamide